@article{TLCR20492,
author = {Giannis Mountzios},
title = {Adjuvant bevacizumab for resected non-small cell lung cancer: the end of an era?},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {Suppl 2},
year = {2018},
keywords = {},
abstract = {The field of adjuvant therapy for surgically resected non-small cell lung cancer (NSCLC) has remained practically unchanged for the last 10–15 years, since the results of several large randomized clinical trials evaluating the benefit of platinum-based chemotherapy after surgery were published (1-4).},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/20492}
}